These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31419931)

  • 1. Colorectal Adenocarcinoma: Imaging using 5-Fluoracil Nanoparticles Labeled with Technetium 99 Metastable.
    Almeida Junior JC; Helal-Neto E; Pinto SR; Dos Santos SN; Bernardes ES; Al-Qahtani M; Nigro F; Alencar LMR; Ricci-Junior E; Santos-Oliveira R
    Curr Pharm Des; 2019; 25(30):3282-3288. PubMed ID: 31419931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
    Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoscintigraphy of colorectal carcinomas with three different radiopharmaceuticals.
    Obradovic V; Artiko V; Petrovic M; Lausevic Z; Stojkovic M; Sobic-Saranovic D; Petrovic N; Vlajkovic M; Krivokapic Z
    Neoplasma; 2006; 53(5):444-9. PubMed ID: 17013541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental focal uptake in colorectal location on oncologic ¹⁸FDG PET and PET/CT studies: histopathological findings and clinical significances.
    Fuertes J; Montagut C; Bullich S; Coma MI; Mestre-Fusco A; Suárez-Piñera M; Trampal C; Bellmunt J
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):95-101. PubMed ID: 25263718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pilot study with the monoclonal antibody IOR-C5 as a potential agent of radioimmunoscintigraphy in colorectal cancer].
    Oliva JP; Pimentel G; Borrón M; Peralta R; Ortiz R; Oliver B; Díaz N; Sánchez I; Vázquez AM; Baum RP
    Rev Esp Med Nucl; 2001 Jun; 20(4):282-8. PubMed ID: 11940415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiolabeling of a new agent for the study of colorectal tumors].
    Quesada Cepero W; Pimentel González G; Oliva González J; Pérez Tenorio G; Aguiar Cabeza E; Sánchez Monzón I; Hernández Romero O; Rebustillo Sierra M
    Rev Esp Med Nucl; 1998; 17(2):82-8. PubMed ID: 9611277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic core mesoporous silica nanoparticles doped with dacarbazine and labelled with 99mTc for early and differential detection of metastatic melanoma by single photon emission computed tomography.
    Portilho FL; Helal-Neto E; Cabezas SS; Pinto SR; Dos Santos SN; Pozzo L; Sancenón F; Martínez-Máñez R; Santos-Oliveira R
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1080-1087. PubMed ID: 29482360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
    Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
    Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiquantitative SPECT tumor uptake of technetium-99m-labeled anti-CEA monoclonal antibody in colorectal tumor.
    Oriuchi N; Endo K; Watanabe N; Sugiyama S; Asao T; Takenoshita S; Nagamachi Y; Baum RP
    J Nucl Med; 1995 Apr; 36(4):679-83. PubMed ID: 7699464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide Nanoparticles Showed Affinity for In Vivo MIA Paca-2 Inducted Pancreas Ductal Adenocarcinoma Mimicking Pancreatic Polypeptide-Secreting Tumor of the Distal Pancreas (PPoma).
    Braga TL; Pinto SR; Dos Reis SRR; Portilho FL; da Silva de Barros AO; Bernardes ES; Dos Santos SN; Alencar LMR; Ricci-Junior E; Santos-Oliveira R
    Pharm Res; 2019 Aug; 36(10):143. PubMed ID: 31385111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer].
    García Vicente A; Soriano Castrejón A; González R; Rodado Marina S; Poblete García VM
    Rev Esp Med Nucl; 2002; 21(5):349-55. PubMed ID: 12236910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From the archives of the AFIP. Colorectal adenocarcinoma: radiologic-pathologic correlation.
    Buetow PC; Buck JL; Carr NJ; Pantongrag-Brown L
    Radiographics; 1995 Jan; 15(1):127-46; quiz 148-9. PubMed ID: 7899592
    [No Abstract]   [Full Text] [Related]  

  • 13. FDG-PET in colorectal cancer.
    de Geus-Oei LF; Ruers TJ; Punt CJ; Leer JW; Corstens FH; Oyen WJ
    Cancer Imaging; 2006 Oct; 6(Spec No A):S71-81. PubMed ID: 17114081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 111In-cetuximab as a diagnostic agent by accessible epidermal growth factor (EGF) receptor targeting in human metastatic colorectal carcinoma.
    Shih YH; Peng CL; Lee SY; Chiang PF; Yao CJ; Lin WJ; Luo TY; Shieh MJ
    Oncotarget; 2015 Jun; 6(18):16601-10. PubMed ID: 26062654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99Tcm-IMMU4 imaging in recurrent colorectal cancer: efficacy and impact on surgical management.
    Sirisriro R; Podoloff DA; Patt YZ; Curley SA; Kasi LP; Bhadkamkar VA; Kim EE; Murray JL; Smith R; Haynie TP
    Nucl Med Commun; 1996 Jul; 17(7):568-76. PubMed ID: 8843115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and technical considerations for imaging colorectal cancers with technetium-99m-labeled antiCEA Fab' fragment.
    Erb DA; Nabi HA
    J Nucl Med Technol; 2000 Mar; 28(1):12-8; quiz 21. PubMed ID: 10763776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroSPECT/CT imaging and pharmacokinetics of 188Re-(DXR)-liposome in human colorectal adenocarcinoma-bearing mice.
    Chen MH; Chang CH; Chang YJ; Chen LC; Yu CY; Wu YH; Lee WC; Yeh CH; Lin FH; Lee TW; Yang CS; Ting G
    Anticancer Res; 2010 Jan; 30(1):65-72. PubMed ID: 20150618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour hypoxia and technetium tracers: in vivo studies.
    Abrantes AM; Serra E; Goncalves C; Oliveiros B; Laranjo M; Sarmento-Ribeiro AB; Rocha-Gonsalves A; Botelho MF
    Curr Radiopharm; 2012 Apr; 5(2):99-105. PubMed ID: 22280110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-IMMU-4 monoclonal antibody scan in colorectal cancer. A prospective study.
    Rodriguez-Bigas MA; Bakshi S; Stomper P; Blumenson LE; Petrelli NJ
    Arch Surg; 1992 Nov; 127(11):1321-4. PubMed ID: 1444794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.